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Introduction: Sepsis is known as a complex immunological response with hyperinflammation in the acute phase
followed by immunosuppression. Although aging is crucial in sepsis, the impact of aging on inflammation and
immunosuppression is still unclear. The purpose of this study was to investigate the relationship between
inflammation and immunosuppression in aged patients and mice after sepsis.
Methods: Fifty-five patients with severe sepsis and 30 healthy donors were prospectively enrolled, and 90-day
survival was compared between elderly (≥65 years) and adult (18–64 years) septic patients with serial measurement
of serum interleukin (IL)-6. Within 24 h after diagnosis of severe sepsis, peripheral blood mononuclear cells were
stimulated ex vivo to measure expression of the activation maker CD25 in T cells, IL-2 levels in the supernatant, and
proliferation. In the mouse study, young (6–8 weeks) and aged (20–22 months) C57/B6 mice were subjected to
cecal ligation and puncture (CLP), and survival was compared after 7 days with serial measurement of serum IL-6.
Expression of the negative co-stimulatory molecules, CD25, and IL-2 in CD4+ T cells was measured.
Results: The survival rate in elderly sepsis patients and aged septic mice was significantly lower than that in adult
patients and young septic mice (60% vs. 93% in septic patients, 0% vs. 63% in septic mice, P < 0.05). Serum IL-6
levels in elderly sepsis patients and aged septic mice were persistently higher than those in adult patients and
young septic mice. Expression of negative co-stimulatory molecules in CD4+ T cells in the spleen, lymph nodes,
and peripheral blood was significantly higher in aged mice than in young mice (P < 0.01). Ex vivo stimulation
decreased CD25 expression, IL-2 production, and proliferation to a greater extent in CD4+ T cells from elderly
patients and aged septic mice than in those from adult patients and young septic mice. Elderly patients
demonstrated increased detection of gram-negative bacteria at days 14–16 and 28–32 after sepsis (P < 0.05).
Conclusions: Persistent inflammation and T cell exhaustion may be associated with decreased survival in elderly
patients and mice after sepsis.Introduction
Sepsis, a systemic inflammatory response to infection, an-
nually kills more than 210,000 people in the United States
[1] and is one of the most challenging clinical problems
worldwide, constituting the leading cause of death in
non-coronary intensive care units [2]. Sepsis initiates
a complex immunologic response that varies over time,
with alternating predominance of both pro-inflammatory
and anti-inflammatory mechanisms [3-6]. After a short* Correspondence: sg-inoue@is.icc.u-tokai.ac.jp
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reproduction in any medium, provided the orpro-inflammatory phase, septic patients are thought to
enter a stage of protracted immunosuppression [6].
Inflammation is characterized by excessive production
of pro-inflammatory mediators [7], and immunosuppres-
sion is characterized by disturbed phagocytosis, antigen
presentation by monocytes with decreased expression
of HLA-DR and dysfunction, and apoptosis of lym-
phocytes, finally leading to shutdown of innate and
adaptive immunity [8]. This phenomenon has recently
been identified as an important cause of mortality during
late-stage sepsis [6,9]. Recently, a genome-wide expression
analysis of severely injured patients revealed that hyperin-
flammation and immunosuppression occur simultaneously
[10], which introduced a new conceptual framework oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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ism syndrome (PICS) [11].
Although aging plays a critical role in the incidence and
outcome of sepsis, the impact of aging on the coincidental
inflammation and immunosuppression is still unclear.
Nearly 60% of sepsis cases occur in patients aged over
65 years, who only comprise 12% of the population
[12,13]. The average age of patients with sepsis is increas-
ing, and age is a known independent predictor of mortal-
ity in sepsis patients [13,14]. We previously reported that
elderly patients have reduced numbers of immunocompe-
tent T cells and persistent lymphopenia with delayed death
after sepsis [15]. However, we did not clarify the relation-
ship between inflammation and immunosuppression in
the elderly after sepsis and did not measure serum levels
or ex vivo production of pro-and anti-inflammatory cyto-
kines. Therefore, the purpose of this study was to further
investigate the relationship between inflammation and im-
munosuppression in aged patients and mice after sepsis.
Materials and methods
Patient study
This study was approved by the ethics board of Tokai
University Hospital in Japan. Patients with severe sepsis
or septic shock and healthy donors (HDs) were pro-
spectively included. Patients who had severe sepsis and
had been admitted to either the emergency department
or ICU were included after written informed consent
was obtained from the patients or their next of kin. In
this study, we used previously reported definitions of
sepsis, severe sepsis, and septic shock [15]. Exclusion cri-
teria included a lack of informed consent, age less than
18 years, pre-existing cancer, hematological or immuno-
logical disease, uncontrolled diabetes, pre-treatment with
immunosuppressive agents, and chronic viral infections
(human immunodeficiency virus or hepatitis B or C).
For comparison, the donors and patients were divided
into two groups based on age: adult (18 to 64 years) and
elderly (≥65 years).
Antibodies
The following human antibodies (Bio-Legend, San Diego,
CA, USA) specific to the surface markers were used: anti-
CD5-Pacific Blue (clone UCHT2) for T cells, anti-CD4-
FITC (clone SK3) for CD4+ T cells, anti-CD44-APC/Cy7
(clone IM7) for memory T cells, anti-CD62L-PerCP/Cy5.5
(clone DREG-56) for naive T cells, and CD25-AlexaFluor
700 (clone BC96) as an activation marker.
Sample collection and analysis of immune cells
The patients were treated according to the standardized
recommendations of the ICU based on Surviving Sepsis
Campaign guidelines [16]. Within 24 h after diagnosis of
severe sepsis, 8 mL of blood sample was collected. Theperipheral blood mononuclear cells (PBMCs) and serum
were separated as previously described [15], and dissoci-
ated PBMCs (1 × 106) were stimulated overnight with
Human T-Activator CD3/CD28 Dynabeads for T-cell
expansion and activation (Life Technologies, Grand
Island, NY, USA), followed by flow cytometric analysis
using a Fortessa Flow Cytometer (BD Biosciences, Franklin
Lakes, NJ, USA) to quantify T-cell activation using FlowJo
software (FlowJo, Ashland, OR, USA). The white blood cell
count was determined from another 2 mL of blood sample
collected at the same time. Cells were fractionated for
neutrophils and monocytes using a XE-2100 automated
hematology analyzer (Sysmex, Kobe, Japan) in the central
laboratory of the hospital.
CFSE labeling and proliferation analysis
PBMC cells (5 × 105) were labeled with 1 μM CellTrace
carboxyfluorescein succinimidyl ester (CFSE) from a cell
proliferation kit (Life Technologies) in PBS for 10 mi-
nutes at 37˚C. The labeling reaction was quenched by
addition of cold Roswell Park Memorial Institute (RPMI)
1640 medium with 10% FCS, and cells were washed twice
with PBS with 2% FCS to remove excess CFSE. The CFSE-
labeled cells were incubated for 48 h with 2.5 μl of Human
T-Activator CD3/CD28 Dynabeads for T-cell expansion
and activation (Life Technologies). Cells were harvested
and stained with anti-CD4 antibodies for fluorescence
activated cell sorter (FACS) analysis based on gating
on individual CFSE generations, and the proliferation of
CD4+ T cells was analyzed.
Cytokine analysis
IL-6 levels in the serum and IL-2 levels in conditioned
medium were quantified using a BD FACS array and In-
flammation Kit (BD Biosciences, Franklin Lakes, NJ, USA)
according to the manufacturer’s recommendations, as pre-
viously described [17]. The lower limits of detection were
1.6 pg/mL for IL-6 and 11.2 pg/mL for IL-2.
Secondary infection analysis
We performed bacterial and fungal cultivation testing for
the patients every 4 to 6 days after ICU hospitalization to
address patients' susceptibility to the secondary infections
after sepsis. Source and types of bacteria and fungus were




Young (6 to 8 weeks) and aged (20 to 22 months) C57/B6
mice were purchased from CLEA, Tokyo, Japan. The mice
were housed in groups of five for at least 1 week prior
to use. All animal studies were approved by the Tokai
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Antibodies
The following murine antibodies (Bio-Legend) specific
to the surface markers were used: anti-CD3-FITC (clone
17A2) and anti CD90.2-AlexaFluor 700(clone 30-H12)
for T cells, anti-CD4-Pacific Blue and APC (clone GK1.5)
for CD4+ T cells, anti-F4/80-PE/Cy7 (clone BN8) and
anti-CD11b-APC (clone M1/70) for macrophages, anti-
Ly-6G/Ly-6C (Gr-1)-PE (RB6-8C5) for neutrophils,
cytotoxic T-lymphocyte antigen 4 (CTLA-4)-APC (clone
UC10-4B9) and programmed death 1(PD-1)-APC (clone
29 F.1A12) as negative co-stimulatory molecules, anti-
CD44-APC/Cy7 (clone IM7) for memory T cells, anti-
CD62L-PE (clone MEL-14) for naive T cells, anti-IL-2-PE
(clone JES6-5H4) for IL-2, and CD25-FITC (clone BC69)
as an activation marker for T cells. Anti-APC Microbeads
were used for CD4+ cell purification (Miltenyi Biotec,
Auburn, CA, USA).
CLP sepsis model
The CLP model developed by Chaudry et al. [18] was
used to induce intra-abdominal peritonitis. In brief, the
mice were anesthetized with isoflurane and a midline
abdominal incision was made. The cecum was mobilized,
half-ligated below the ileocecal valve, and punctured once
using a 27-gauge needle. The abdomen was closed in two
layers, and the mice were subcutaneously injected with
1.0 mL of 0.9% saline containing 2 μg of buprenorphine
for analgesia. No fluids or antibiotics were administered to
mice that underwent the operation. The mice used for
analysis of absolute cell counts and cytokine production
were sacrificed at 24 h post surgery. For the survival stud-
ies, the mice underwent CLP as described above, and the
analysis was discontinued at 7 days after surgery. One-
drop blood collection from the cheek plexus of other
groups of CLP mice was used for cytokine assays at 3, 6,
12, 18, 24, and 48 h after CLP.
Cytokine analysis
Serum cytokine levels were quantified using the BD
FACS array as described for the patient study. The lower
limit of detection was 1.4 pg/mL for IL-6, 9.6 pg/mL for
IL-10, and 2.7 pg/mL for monocyte chemoattractant
protein-1 (MCP-1).
Harvesting of blood, spleen, and lymph nodes
At approximately 24 h post surgery, blood was collected
from the heart of anesthetized mice using a heparinized
syringe. PBMCs were separated using Histopaque®-1083
(Sigma-aldrich, St Louis, MO, USA). Next, mice were gen-
tly sacrificed by cervical dislocation under sedation, and
the spleen and mesenteric lymph nodes were surgicallyremoved and prepared by gently pressing the organs
through a 70-μm filter and the cells were then washed
and the red cells were lysed. PBMCs and dissociated sple-
nocytes (1 × 106) were stained for cell surface markers and
quantified by flow cytometry. CD4+ T cells from spleno-
cytes were purified using a magnetic activated cell sorter
(auto-MACS, Miltenyi Biotec) and FACS (Aria II, BD
Biosciences).
Assay for ex vivo activation of T cells
Spleens from young and aged mice were harvested, sple-
nocyte suspensions were prepared, and the cells were
stimulated as previously described [19]. The dissociated
splenocytes and sorted CD4+ T cells (1 × 106) were stim-
ulated overnight using an anti-CD3 antibody followed by
staining to identify CD4+ T cells and quantification of
the activation marker CD25 and IL-2 by flow cytometry.
CFSE labeling and proliferation analysis
Splenocytes (5 × 105) were labeled with the Cell Trace
CFSE Cell Proliferation kit as described for the human
PBMC CFSE assay. CFSE-labeled cells were incubated
for 48 h with anti-CD3 antibody and CD4+ T cell prolif-
eration was analyzed.
Statistical methods
Data were analyzed using IBM SPSS Statistics version 20
(SPSS, Chicago, IL, USA). Two-way analysis of variance
(ANOVA) was performed to determine the main effects
of sepsis (HDs versus sepsis or sham versus CLP) and
aging (adult versus elderly or young versus aged), as well
as the interaction between these two factors.
Survival curves were created with the Kaplan-Meier
method and compared using the log-rank test. Cox pro-
portional hazards regression analysis was used to deter-
mine the net effect of each predictor while controlling for
the effects of the other factors by multivariate analyses.
The hazard ratio (HR) with 95% CI was used to assess the
independent contributions of significant factors. To evalu-
ate the impact of comorbidities on severe sepsis, we also
performed sensitivity analysis by excluding patients with
comorbidities that were more prevalent in elderly patients
than in adult patients; then, we compared the outcomes
between the remaining adult and elderly patients with
sepsis.
A mixed-effect regression model was used to test the
difference in cytokine levels pooled over time in the
young and elderly groups (time-adjusted difference).
The following covariance structures were considered:
unstructured, compound symmetric, first-order auto-
regressive, and Toeplitz. The covariance structure that
provided the best fit according to Akaike’s information
criterion was used in the analysis. P <0.05 was defined as
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Results
Decreased survival and persistent inflammation in severe
sepsis in elderly patients and in aged septic mice
Fifty-five patients with severe sepsis and thirty HDs were
enrolled in the current study (Figure 1). The study
participants were divided into two groups based on
age: adult (18 to 64 years) and elderly (≥65 years). The
clinical characteristics of the respective groups are sum-
marized in Table 1. The 3-month survival of elderly septic
patients (60%) was significantly lower than that of adult
sepsis patients (93%, P <0.05; Figure 2A). Multivariate ana-
lysis using Cox proportional hazard regression showed
that age was the strongest predictor of 3-month mortality
in the patients (HR, 1.07; 95% CI, 1.01, 1.13; P = 0.02)
(Table 2). The serum IL-6 concentration was consistently
higher in elderly sepsis patients than in adult sepsis
patients; the mean difference between the groups was 354
to 13,095 pg/mL (P <0.01; Figure 2A). We analyzed serum
albumin levels at day 1 and day 30 after sepsis in the
patients to address the impaired catabolism in the
elderly patients. We found decreased serum albumin
levels in the septic elderly patients compared to adult
patients at both 1 and 30 days after sepsis (P <0.05 in
elderly survivors, P <0.01 in elderly non survivors)
(Additional file 1).
In the murine study, the 7-day survival of the aged
mice (0%) was significantly lower than that of the young
mice after CLP (63%, P <0.05). The majority of the aged
CLP-mice rapidly deteriorated at 24 to 48 h after surgery,
and all the mice died within 72 h (Figure 2B). The serum









Figure 1 Flow chart of patients included in this study.sepsis group than in the young sepsis group; the mean dif-
ference between the groups was 11,514 to 28,870 pg/mL
(P <0.01; Figure 2B). Similar tendencies with regard to
kinetics and quantities were observed in analyses of serum
MCP-1 and IL-10 levels in the sepsis groups (P <0.01,
Figure 2B). Persistent inflammation with greatly enhanced
myeloperoxidase activity of activated phagocytes was
observed in the aged mice from 6 h to 12 h after
CLP on in vivo imaging, whereas mild inflammation
was observed in the young mice at 6 h but not 12 h after
CLP (Additional file 2).
Increased population of neutrophils and macrophages in
peripheral blood and lymph nodes of aged mice
Sepsis induced a significant increase in circulating
neutrophils and monocytes in both adult and elderly
patients within 24 h after diagnosis, without a significant
difference between adult and elderly patients (P <0.01;
Figure 3A). In contrast to the human cohort, aged
mice demonstrated an increased number of neutro-
phils and macrophages in both the peripheral blood and
lymph nodes relative to young mice (Figure 3B).
Decreased proportion of naïve T cells and increased
proportion of memory T cells in severe sepsis in elderly
humans and aged mice
Flow cytometric analysis demonstrated a decreased pro-
portion of naïve T cells (CD62L + CD44-) in peripheral
blood from elderly humans and spleens from aged
mice relative to adult humans and young mice (Figure 4,
P <0.01). An increased proportion of memory T cells
(CD62L- CD44+) was observed in peripheral blood from
elderly humans and spleens from aged mice relative to
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Table 1 Characteristics of healthy donors and severe septic patients for cytokine analysis in serum
Adult patients Elderly patients P-value
Healthy donors, number 14 16
Age, y, mean ± SD 24.0 ± 8.1 78.4 ± 8.2 <0.001
Male, n (%) 11 (79) 11 (69) 0.45
Comorbidity, n (%) 0 (0) 5 (31) 0.30
Severe sepsis, number of patients 15 40
Age, y, mean ± SD 34.8 ± 11.9 77.6 ± 7.1 <0.001
Male, n (%) 12 (80) 28 (70) 0.45
Septic shock, n (%) 5 (33) 18 (45) 0.43
Ventilator rate, n (%) 11 (73) 31 (78) 0.75
APACHE II score, mean ± SD 19.2 ± 6.9 22.5 ± 6.9 0.14
APACHE II-age score, mean ± SD 19.0 ± 5.0 15.8 ± 7.6 0.08
SAPS II score, mean ± SD 46.6 ± 17.5 58.6 ± 16.1 0.10
SAPS II-age score, mean ± SD 43.3 ± 9.6 42.7 ± 11.6 0.17
SOFA score, mean ± SD 7.4 ± 4.6 7.3 ± 4.1 0.87
Comorbidity, n (%) 4 (27) 31 (78) 0.01
Types of bacteria detected in first 72 h, n (%)
Gram-positive bacteria 8 (53) 22 (55) 0.91
Gram-negative bacteria 15 (100) 40 (100) 1.00
Fungi 6 (40) 17 (43) 0.87
Treatment, n (%)
Adjunctive hydrocortisone, n (%) 1 (7) 2 (5) 0.81
Organ support types
Ventilator, n (%) 12 (80) 35 (86) 0.48
Hemofiltration, n (%) 3 (20) 10 (25) 0.70
Organ support duration
Ventilator, d, mean ± SD 11.6 ± 12.3 9.3 ± 16.1 0.68
Hemofiltration, d, mean ± SD 7.3 ± 6.6 9.9 ± 12.8 0.26
ICU stay, d, mean ± SD 21.9 ± 22.6 16.6 ± 16.1 0.57
ICU-free days in 28 days, d, mean ± SD 11.6 ± 9.6 10.9 ± 11.6 0.64
Hospital stay, d, mean ± SD 36.3 ± 35.9 39.6 ± 41.9 0.41
APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, The Sequential Organ Failure Assessment score; SAPS, Simplified Acute Physiology Score.
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in CD4+ T cells in aged mice
Flow cytometric analysis revealed a significant increase
in the number of CD4+ T cells expressing PD-1, which
is a known negative co-stimulatory molecule, in aged
mice relative to young mice (5.7-fold in the spleen and
7.5-fold in the lymph nodes; P <0.01; Figure 5). The
number of CD4+ T cells expressing CTLA-4, which is
also a negative co-stimulatory molecule, was significantly
higher in aged mice than in young mice (3.3-fold in the
spleen and 4.0-fold in the lymph nodes; P <0.01). In per-
ipheral blood, sepsis induced a significant increase of
PD-1 and CTLA-4 expression in CD4+ T cells in young
and aged mice. The increased number of cells expressing
negative co-stimulatory molecules was likely associatedwith the impaired activation of T cells in aged mice.
These age-related immunological changes may contribute
to immunosuppression in aged sepsis.
Impaired activation of T cells in severe sepsis in elderly
patients and in aged septic mice
The patients’ blood samples were collected within 24 h
after diagnosis of severe sepsis. The characteristics of the
ex vivo stimulation assay described below are listed in
Additional file 3. Upon activation using an anti-CD3/28
antibody, CD25 expression in CD4+ T cells was lower in
adult and elderly patients than in HDs, which suggests
that immunosuppression occurred even in the relatively
early phase of sepsis. Importantly, the impact of aging
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Figure 2 Decreased survival and prolonged elevation of serum pro- and anti-inflammatory cytokines in severe sepsis in elderly
patients. (A) Left, survival rates of adult and elderly patients with sepsis; right, serum concentrations of IL-6 after diagnosis. (B) Upper left, survival
rates of aged and young mice after cecal ligation and puncture (CLP) (P = 0.015, n = 8 per group); serum concentrations of IL-6 (upper right),
monocyte chemoattractant protein-1 (MCP-1) (lower left) and IL-10 (lower right) in young and aged mice after CLP (P <0.01).
Table 2 Multivariate analysis of clinical features and
survival of patients with severe sepsis
Variable P-value Hazard ratio 95% CI
Lower Upper
Age 0.02 1.07 1.01 1.13
SOFA 0.32 1.08 0.93 1.26
Comorbidity 0.99 1.16 0.28 1.26
SOFA, sequential organ failure assessment.
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that T-cell activation is impaired in aged individuals
irrespective of infection status (Figure 6A). Similar to
the results observed in human cells, both aging and
sepsis induced a reduction of CD25 expression in
mouse CD4+ T cells upon ex vivo stimulation by an anti-
CD3 antibody (P <0.05; Figure 6D). Purified CD4+ T
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Figure 3 Increased population of neutrophils and macrophages in peripheral blood and lymph nodes of aged mice. (A) Neutrophils and
monocytes in the peripheral blood of adult and elderly cohorts were counted by an automated hematology analyzer; n = 14 to 40 per group,
*P <0.05. (B) Populations of neutrophils (Gr1+/CD11b+) and monocytes (F4/80+) in peripheral blood and mesenteric lymph nodes from CLP- and
sham-treated mice were identified by flow cytometric analysis; n = 10 to 12 per group, **P <0.01, *P <0.05.
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tients and in aged mice
We measured the IL-2 concentration in the supernatants
of human PBMCs incubated overnight with an anti-
CD3/CD28 antibody. In both elderly and septic subjects,
IL-2 concentrations were significantly reduced (P <0.05)
(Figure 6B). We also examined IL-2 expression in CD3/
28-stimulated CD4+ T cells of spleens from young and
aged mice by flow cytometry. Aged CD4 T cells produced
lower amounts of IL-2 (Figure 6E).
Impaired proliferation of CD4 + T cells in severe sepsis in
elderly patients and in aged mice
Population doubling of CD4+ T cells was observed in
adult HDs and septic patients as a decrease in CFSEfluorescence. Impaired proliferation was observed in
CD4+ T cells from elderly HDs and septic patients
(Figure 6C). Similar to the results obtained in elderly
humans, impaired proliferation was observed in CD4+ T
cells from aged sham-treated mice and aged CLP mice,
suggesting age-related T-cell exhaustion (Figure 6F).
Increased secondary infection in elderly septic patients
To address how the observed T cell exhaustion affects
secondary infections after sepsis, we performed bacterial
and fungal cultivation testing for the patients after ICU
hospitalization. Elderly patients were more susceptible of
secondary infection than adult patients, with increased
detection of gram-negative bacteria at days 14 to 16 and
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Figure 4 Decreased proportion of naïve T cells and increased proportion of memory T cells in severe sepsis in elderly patients and
aged mice. Decreased numbers of naïve T cells (CD62L + CD44-) and increased numbers of memory T cells (CD62L- CD44+) among CD4+ T cells
were observed in peripheral blood from elderly patients and spleens from aged mice relative to adult humans and young mice by flow
cytometric analysis (P <0.01); n = 14 to 25 in patients/healthy donors (HDs) and 6 to 8 in mice, per group **P <0.01.
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outcomes
To address how comorbidities affected the primary out-
come in this study, we performed sensitivity analysis, in
which we excluded 10 patients with cerebrovascular dis-
eases because this comorbidity is significantly increased
in the elderly. Three-month survival was significantly de-
creased in elderly patients compared with adult patients
(93% versus 60%; P <0.05), which is consistent with the
primary outcome (Additional file 5). After this exclusion,
serum IL-6 levels at 24 h after sepsis and the percentage
of CD44+ memory CD4+ T cells were still significantly
increased, whereas the percentage of CD62L + naïve
CD4+ T cells was significantly decreased in elderly
patients with sepsis compared with adult patients with
sepsis (P <0.05). In the ex vivo stimulation study, the
percentage of CD25+ activated CD4+ T cells and the
IL-2 concentration in the supernatants also significantly
decreased in elderly patients with sepsis compared with
adult patients with sepsis (P <0.05).
Discussion
We observed persistent inflammation and T-cell exhaustion
in aged mice and elderly patients after sepsis with lower
survival rates compared to their younger counterparts. Itwas previously reported that sepsis patients show a sys-
temic inflammatory response, often termed the cytokine
storm, in the early stage of sepsis and often develop
immunosuppression in the late stage [20-22]. However,
our results indicate that excessive inflammation continues
for at least 6 days in septic elderly patients and 48 h in
aged septic mice, as prolonged elevation of IL-6 in elderly
patients and of IL-6, MCP-1, and IL-10 in aged CLP mice
was observed (Figure 2A and B, respectively). Therefore,
inflammation does not cease in the early stage of sepsis.
However, impaired T cell activation, IL-2 production, and
proliferation were observed in elderly sepsis patients and
aged mice at relatively early stages (24 h after diagnosis in
humans and after CLP treatment in mice). It is suggested
that prolonged inflammation and T-cell exhaustion
occurred simultaneously [11].
Although aged mice contained more neutrophils and
macrophages in their peripheral blood and lymph nodes
than young mice (Figure 3B), there was no significant
difference in neutrophil and monocyte number between
adult and elderly humans (Figure 3A). Furthermore,
there was no age difference in the cytokine production
(IL-6, MCP-1, TNF-a, and IL-10) of human PBMCs and
mouse macrophages and neutrophils that were stimulated
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Figure 5 Increased expression of negative co-stimulatory molecules in CD4+ T cells in aged mice. The proportions of CD4+ T cells
expressing PD-1 (left) and CTLA-4 (right) in the spleen, lymph nodes, and peripheral blood were compared between young and aged cecal
ligation and puncture (CLP)- or sham-treated mice at 24 h post surgery; n = 6 per group, **P <0.01, *P <0.05.
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different between young and aged mice (data not shown).
Although it is possible that an increase in neutrophils or
macrophages contributes to enhanced inflammation in
aged CLP mice, such an increase does not appear to play a
role in the observed effects in humans.
A commonly observed feature of human and mouse
sepsis is T-cell exhaustion (Figures 5 and 6). The term
exhaustion has been used to describe the state of func-
tional unresponsiveness, replicative senescence, and ultim-
ate physical deletion of T cells during chronic infection in
mice and humans [23,24]. We demonstrated that CD4+ T
cells in elderly humans and aged mice showed impaired
IL-2 receptor (IL-2R) expression (Figure 6A and D), IL-2
production (Figure 6B and E), and cell division (Figure 6C
and F). Furthermore, the fraction of PD-1/cytotoxic T-
lymphocyte antigen 4 (CTALA-4) expressing-CD4+ T
cells was higher in aged mice than in young mice
(Figure 5), as we have previously reported in humans
[15]. Several features of T-cell exhaustion describedabove are consistent with previous reports [9,25-29].
T-cell exhaustion is a newly recognized pathophysiologic
mechanism of immunosuppression in sepsis that results
in failure to activate macrophages and to eradicate invad-
ing pathogens, thereby increasing susceptibility to second-
ary infections, leading to prolonged inflammation. In this
study, we also showed that elderly septic patients suffered
from secondary infection at 2 and 4 weeks after sepsis,
especially infection by gram-negative bacteria (Table 3).
Taken together, these findings suggest that T-cell ex-
haustion in elderly patients may be associated with
prolonged inflammation and presumably decreased sur-
vival after sepsis.
Although our study demonstrated several similarities
in the immune response between patients and mice,
some findings in aged mice did not match those in
elderly patients. First, CD28 expression in CD4+ T cells
was decreased in elderly humans [15], whereas there was
no difference between young and aged mice (data not
shown). Second, IFN-γ production in CD4+ T cells was
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Figure 6 Impaired ex vivo activation, IL-2 production, and proliferation of CD4 + T cells from elderly patients and aged mice with
severe sepsis. (A) Dissociated peripheral blood mononuclear cells were stimulated ex vivo overnight with an anti-CD3/CD28 antibody, followed
by flow cytometric analysis to quantify T cell activation. (B) IL-2 concentration in supernatants from peripheral blood mononuclear cells (PBMCs)
with overnight stimulation by anti-CD3/CD28 antibody. (C) Profiles of carboxyfluorescein succinimidyl ester (CFSE) fluorescence intensity of
activated PBMC cultures. Population doubling of CD4+ T cells can be clearly assessed by the decrease in CFSE fluorescence. Impaired proliferation
was observed in CD4+ T cells from elderly healthy donors (HDs) and septic patients; n = 6 to 14 per group, *P <0.05, **P <0.01. (D) Dissociated
splenocytes were stimulated overnight using the anti-CD3 antibody followed by staining for CD4+ T cells and quantification of the activation
marker CD25 by flow cytometry ex vivo; n = 6 per group, *P <0.05, **P <0.01. (E) Percentage of IL-2-secreting CD4+ T cells on overnight
incubation with an anti-CD3 antibody. (F) Population doubling of CD4+ T cells from young and aged splenocytes can be clearly assessed by the
decrease in CFSE fluorescence. Impaired proliferation was observed in CD4+ T cells from aged sham and CLP mice; n = 6 to 8 per group, *P <0.05.
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mice (data not shown). Consistent with our findings,
some reports have shown that aging increases IFN-γ
production [30-34]. In contrast, other reports have shown
that aging reduces IFN-γ production in mice [35-37],
whereas Kovacs et al. reported that IFN-γ production did
not differ between young and aged mice with both sham
and experimental burn injury [38]. Therefore, the impact
of aging on IFN-γ production is still controversial. Re-
cently, Seok et al. reported that genomic responses against
endotoxemia, especially in T cells, are quite different
between humans and mice [39]. Therefore, speciesTable 3 Source and types of secondary infection in the patien
Day 14 to 16
Adult (n = 14) Elderly (n = 34)
Source, n (%)
Sputum 1 (7) 13 (38)
Blood 0 (0) 4 (12)
Urine 1 (7) 7 (21)
Wound 1 (7) 4 (12)
Total 3 (21) 28 (82)
Gram-positive, n (%)
S. aureus 0 (0) 1 (3)
S. epidermidis 1 (7) 1 (3)
MRSA 1 (7) 3 (9)
Others 4 (29) 6 (18)
Total 6 (43) 11 (32)
E. Coli 0 (0) 3 (9)
P. aeruginosa 0 (0) 2 (6)
Klebsiella pneumoniae 1 (7) 2 (6)
Acinetobactor 0 (0) 2 (6)
S. maltophilia 0 (0) 5 (15)
Others 1 (7) 3 (9)
Total 2 (14) 17 (50)
C. albicans 1 (7) 10 (29)
Aspergius fumigatus 0 (0) 1 (3)
Total 1 (7) 11 (32)
MRSA, methicillin-resistant Staphylococcus aureus; S. aureus, Staphylococcus aureus; S.
Pseudomonas aeruginosa; S. maltophilia, Stenotrophomonas maltophilia; C. albicans, Cdifferences in the immune response should be carefully
considered when designing translational studies in sepsis.
Several limitations of this study must be noted. The
overall sample size of this prospective study was rela-
tively small, and all of the study participants were from a
single center. The treatment after sepsis in mice in this
study was different from that in patients because no fluids
or antibiotics were administered to mice that underwent
the CLP operation. In addition, the sample size of the
ex vivo stimulation study was small.
Another point to discuss is the timing of death after
CLP in aged mice. Aged mice subjected to CLP startedts after sepsis
Day 28 to 32
P-value Adult (n = 14) Elderly (n = 29) P-value
1 (7) 10 (34)
0 (0) 1 (3)
1 (7) 4 (14)
1 (7) 1 (3)
<0.01 3 (21) 16 (55) <0.05
1 (7) 1 (3)
0 (0) 1 (3)
1 (7) 4 (14)
0(0) 6 (21)
0.49 2(14) 12 (41) 0.08
0 (0) 0 (0)
0 (0) 1 (3)
0 (0) 1 (3)
0 (0) 1 (3)
0 (0) 5 (17)
0 (0) 4 (14)
<0.05 0 (0) 12 (41) <0.01
1 (7) 5 (17)
0 (0) 0 (0)
0.06 1 (7) 5 (17) 0.67
epidermidis, Staphylococcus epidermidis; E. Coli, Escherichia coli; P. aeruginosa,
andida albicans.
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innate immunity was also dysfunctional in these mice.
However, some young mice also started to die at this
time point (Figure 2B). Klotho knockout mice, in which
both innate and adaptive immunity are severely im-
paired, have been found to die at a much earlier phase at
8 to 12 h after CLP [40]. Therefore, we can assume that
the innate immune system was relatively functional in
aged mice. The study endpoint of 24 h after CLP may be
early to evaluate T-cell immunity; however, 24 h was the
latest time point available in this study. Further studies
are needed to elucidate these points.
Conclusion
Elderly septic patients and mice presented prolonged
serum IL-6 elevation, impaired CD4+ T cell activation
with increased expression of PD-1 and CTLA-4, and im-
paired IL-2 production and proliferation of CD4+ T cells
ex vivo. Persistent inflammation and T-cell exhaustion
may be associated with decreased survival in aged mice
and elderly patients after sepsis.
Key messages
 Decreased survival and persistent elevation of serum
IL-6 levels was observed in severe sepsis in elderly
patients and aged septic mice.
 Aging decreased the proportion of naive T cells and
increased that of memory CD4+ T cells with high
expression of negative co-stimulatory molecules in
patients and mice with or without sepsis.
 Aging and sepsis induces T-cell exhaustion with
impaired activation, IL-2 production, and
proliferation in patients and mice.
 Elderly patients were more susceptible to secondary
infection than adult patients, with increased
detection of gram-negative bacteria at days 14 to 16
and 28 to 32 after sepsis (P <0.05).
 Persistent inflammation and T-cell exhaustion may
be associated with decreased survival in aged mice
and elderly patients after sepsis.
Additional files
Additional file 1: Decreased serum albumin in elderly non survivors
after sepsis. Serum albumin at day 1 and day 30 after sepsis was
measured and analyzed to address impaired catabolism in elderly
patients. Decreased serum albumin was observed in the septic elderly
patients compared to adult patients at day 1 and 30 days after sepsis;
n = 14 to 29 per group, *P <0.05, **P <0.01.
Additional file 2: Extensive and prolonged inflammation in the
peritoneal cavity of aged mice after cecal ligation puncture.
Aged mice demonstrated prolonged inflammation, reflected by high
luciferase activity, which tracks the myeloperoxidase activity of activated
phagocytes and inflammation, at 6 and 12 h after cecal ligation puncture.
The mild inflammation observed in the young mice at 6 h after cecalligation puncture disappeared at 12 h after the procedure. Methods: the
IVIS Imaging System (100 Series; Xenogen Corp., Alameda, CA, USA) was
used for in vivo imaging as previously described [41]. At 0, 6, and 12 h
after CLP, mice were anesthetized with isoflurane and intraperitoneally
injected with 150 mg/kg luciferin (Biosynth, AG, Switzerland), which
traces myeloperoxidase from activated phagocytes. At 10 minutes after
luciferin injection, the mice were imaged for 5 minutes. Photons emitted
from specific regions were quantified using Living Image software
(Xenogen Corporation). The in vivo luciferase activity was expressed as
photons per second per centimeter square. The color overlay on the
image represents the photons per second emitted from the animal in
accordance with the pseudo-color scale next to the images. Red
represents the highest value in photons per second, whereas blue
represents the lowest value. CLP, cecal ligation puncture.
Additional file 3: Characteristics of healthy donors and severe
septic patients for ex vivo stimulation of T cells.
Additional file 4: Inactivation of purified CD4+ T cells form aged
splenocytes. The dissociated splenocytes and sorted CD4+ T cells were
stimulated overnight using an anti-CD3 antibody followed by staining to
identify CD4+ T cells and quantification of the activation marker CD25.
Purified CD4+ T cells of aged mice also showed insufficient activation.
MACS, magnetic activated cell sorter. FACS, fluorescence activated
cell sorter.
Additional file 5: Sensitivity analysis by excluding patients with
cerebrovascular diseases.
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